Filing Details

Accession Number:
0001484612-23-000053
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-05 17:39:17
Reporting Period:
2023-07-03
Accepted Time:
2023-07-05 17:39:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1484612 Outset Medical Inc. OM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304125 Leslie Trigg 3052 Orchard Drive
San Jose CA 95134
Chair And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-07-03 20,000 $4.11 429,489 No 4 M Direct
Common Stock Disposition 2023-07-03 20,000 $20.90 409,489 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Options (right to buy) Disposition 2023-07-03 20,000 $0.00 20,000 $4.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,418 2028-11-03 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,770 Indirect Trigg Family Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.
  2. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00 - $20.99 - 13,150 shares; and $21.00 - $21.99 - 6,850 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.
  3. In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.